• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Discovery and structural characterization of chicoric acid as a SARS-CoV-2 nucleocapsid protein ligand and RNA binding disruptor

tetano

Editor, Senior Moderator
Sci Rep


. 2022 Nov 2;12(1):18500.
doi: 10.1038/s41598-022-22576-4.
Discovery and structural characterization of chicoric acid as a SARS-CoV-2 nucleocapsid protein ligand and RNA binding disruptor


Gustavo Fernando Mercaldi[SUP] #[/SUP][SUP] 1 [/SUP], Eduardo Henrique Salviano Bezerra[SUP] #[/SUP][SUP] 1 [/SUP], Fernanda Aparecida Heleno Batista[SUP] #[/SUP][SUP] 1 [/SUP], Celisa Caldana Costa Tonoli[SUP] 1 [/SUP], Adriana Santos Soprano[SUP] 1 [/SUP], Jacqueline Farinha Shimizu[SUP] 1 [/SUP], Alice Nagai[SUP] 1 [/SUP], Jaqueline Cristina da Silva[SUP] 1 [/SUP], Helder Veras Ribeiro Filho[SUP] 1 [/SUP], Jéssica do Nascimento Faria[SUP] 1 [/SUP], Marcos Guilherme da Cunha[SUP] 1 [/SUP], Ana Carolina Mattos Zeri[SUP] 2 [/SUP], Andrey Fabricio Ziem Nascimento[SUP] 2 [/SUP], José Luiz Proenca-Modena[SUP] 3 4 [/SUP], Marcio Chaim Bajgelman[SUP] 1 [/SUP], Silvana Aparecida Rocco[SUP] 1 [/SUP], Paulo Sérgio Lopes-de-Oliveira[SUP] 1 [/SUP], Artur Torres Cordeiro[SUP] 1 [/SUP], Marjorie Bruder[SUP] 1 [/SUP], Rafael Elias Marques[SUP] 1 [/SUP], Mauricio Luis Sforça[SUP] 1 [/SUP], Kleber Gomes Franchini[SUP] 1 [/SUP], Celso Eduardo Benedetti[SUP] 1 [/SUP], Ana Carolina Migliorini Figueira[SUP] 5 [/SUP], Daniela Barretto Barbosa Trivella[SUP] 6 [/SUP]



Affiliations
Free article

Abstract

The nucleocapsid (N) protein plays critical roles in coronavirus genome transcription and packaging, representing a key target for the development of novel antivirals, and for which structural information on ligand binding is scarce. We used a novel fluorescence polarization assay to identify small molecules that disrupt the binding of the N protein to a target RNA derived from the SARS-CoV-2 genome packaging signal. Several phenolic compounds, including L-chicoric acid (CA), were identified as high-affinity N-protein ligands. The binding of CA to the N protein was confirmed by isothermal titration calorimetry, [SUP]1[/SUP]H-STD and [SUP]15[/SUP]N-HSQC NMR, and by the crystal structure of CA bound to the N protein C-terminal domain (CTD), further revealing a new modulatory site in the SARS-CoV-2 N protein. Moreover, CA reduced SARS-CoV-2 replication in cell cultures. These data thus open venues for the development of new antivirals targeting the N protein, an essential and yet underexplored coronavirus target.
 
Back
Top Bottom